People with Obesity Have 2 Times the Risk of Hospitalization Due to COVID-19

Through new analyses, scientists confirmed that obesity (excess weight) and COVID-19 have a definite link: the risk of hospitalization in people with obesity was found to be 113% higher, while their risks of a COVID-19 diagnosis, intensive care treatment and death were 46% higher as well.
In this new study of obesity and COVID-19, the results of 75 studies published between January and June, including 399,461 patients diagnosed with COVID-19, were reanalyzed and compared. Among studies comparing different components, 18 of 20 found that obesity increased the risk of a COVID-19 diagnosis, while all of another 19 studies found that it increased the risk of hospitalization. In 21 of 22 studies, people with obesity were more likely to require continued intensive care treatment, while 27 of 35 studies found that excess weight gain increased the risk of death. The researchers also found that obesity increased the risk of requiring mechanical ventilation in 14 published studies. They say they had not expected such a large increase and found the results extremely surprising.
Dr. Popkin, a researcher in the study, says, “Looking at the biological side, we know that the immune system in people with obesity is much weaker. Excess weight therefore impairs lung function, causing people diagnosed with COVID-19 to have more critical and severe presentations. Excess weight could also affect drugs used in COVID-19 treatment, such as ACE inhibitors, potentially altering how effectively these agents work”, emphasizing that COVID-19 is far more complex than previously thought.
Based on these data, the researchers add, “Studies in patients vaccinated against influenza (flu) demonstrate that T-cell responses and antibody production in people with excess weight are lower. We also know that obesity causes high levels of inflammation in the body and leaves it vulnerable. On this basis, we can say that vaccines developed for COVID-19 will, because of the weakened immune system in people with excess weight, be less effective. Taking all this into account, patients in vaccine studies should be grouped as obese and non-obese, and vaccine efficacy should be determined with this distinction considered.”
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.